Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Stem Cells is Scopus-indexed (Q1, CiteScore 7.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Oxford University Press.
Checked against the index lists dated .
ISSN 1066-5099Verify ISSN ↗1549-4918Verify ISSN ↗
Publisher: Oxford University Press
Cost to publish: About US$4,477 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Developmental Biology | 16 / 78 | 80th | Q1 |
| Molecular Medicine | 58 / 179 | 67th | Q2 |
| Cell Biology | 105 / 289 | 63rd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1993–present (also 1981–1982), best quartile Q1, CiteScore 7.3.
Stem Cells is Q1 in Developmental Biology (rank 16 of 78), Q2 in Molecular Medicine (rank 58 of 179) and Q2 in Cell Biology (rank 105 of 289), by CiteScore 2025.
Stem Cells is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.3, which places it in quartile Q1 at the 80th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.244, quartile Q1, with an H-index of 264.
The publisher lists an article processing charge of about US$4,477 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Stem Cells is published by Oxford University Press. Its print ISSN is 1066-5099 and its online ISSN is 1549-4918.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Stem Cells has an h-index of 288 and a 2-year mean of 3.68 citations per paper (OpenAlex). Its Scopus CiteScore is 7.3, quartile Q1. On 2-year citations it ranks #24 of 76 Scopus journals in Developmental Biology.
Stem Cells published 91 papers in 2025; its busiest recent year was 2018 with 209. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from United States (31.1%), China (24.6%) and United Kingdom (5.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 13 retracted papers are recorded (2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.